Since skeletal muscle dysfunction contributes most to the impairment of systemic insulin sensitivity and the compensatory occurrence of hyperinsulinemia, future research should address in depth the pathophysiological processes in the skeletal muscle of obese individuals with PCOS and identify potential therapeutic targets. The gene discussed is INS; the disease is polycystic ovary syndrome.